RPRX
Royalty Pharma plc
+0.46 (+0.79%)58.93USD653K成交股數22.9B市值31.5本益比(近四季)9.0股價營收比+16.5%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 674M+16% | 631M+11% | 622M+10% | 609M+13% | 579M+2% | 568M-5% | 565M+5% | 537M-0% | 568M | 596M | 536M | 538M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 97.9M | 39.8M | 50.5M | 50.5M | 301M | 50.5M | 500K | 500K | 500K | 500K | 50.5M | 500K |
| 銷售管理費用 | 162M | 159M | 164M | 119M | 180M | 111M | 56.7M | 54.7M | 57.7M | 59.2M | 57.2M | 47.6M |
| 營業利益 | 133M-37% | 563M+5% | 388M-47% | 427M+58% | 210M-384% | 534M-13% | 735M+385% | 270M+8% | −73.8M | 613M | 151M | 249M |
| 營業利益率 | 19.7% | 89.3% | 62.4% | 70.1% | 36.3% | 94.0% | 130.2% | 50.2% | -13.0% | 102.8% | 28.2% | 46.2% |
| 稅後淨利 | 17.9M-44% | 295M+23% | 211M-61% | 288M+183% | 32.2M+573% | 239M-52% | 544M+654% | 102M-55% | 4.8M | 494M | 72.1M | 228M |
| 淨利率 | 2.7% | 46.7% | 34.0% | 47.3% | 5.6% | 42.1% | 96.3% | 19.0% | 0.8% | 82.9% | 13.4% | 42.3% |
| 稀釋 EPS | 0.04-43% | 0.67+22% | 0.49-60% | 0.67+191% | 0.07+600% | 0.55-50% | 1.21+656% | 0.23-54% | 0.01 | 1.11 | 0.16 | 0.50 |
| 稀釋股數 | 557M | 557M | 564M | 560M | 562M | 578M | 593M | 597M | 597M | 603M | 601M | 606M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 812M | 586M | 619M | 939M | 632M | 1.1B | 950M | 1.8B | 843M | 477M | 936M | 2.2B |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 19.8B | 19.8B | 19.6B | 19.3B | 18.3B | 17.6B | 18.0B | 17.7B | 16.1B | 16.4B | 15.9B | 17.1B |
| 有息負債 | 8.6B | 8.6B | 8.6B | 8.6B | 7.0B | 6.6B | 6.6B | 7.6B | 6.1B | 6.1B | 6.1B | 6.1B |
| 總負債 | 10.0B | 9.9B | 9.9B | 9.7B | 8.8B | 7.8B | 7.8B | 7.9B | 6.3B | 6.3B | 6.3B | 7.3B |
| 股東權益 | 9.8B | 9.9B | 9.7B | 9.6B | 9.5B | 9.8B | 10.3B | 9.8B | 9.9B | 10.1B | 9.6B | 9.8B |
| 負債比 | 50.6% | 49.9% | 50.5% | 50.3% | 48.1% | 44.4% | 43.1% | 44.8% | 38.9% | 38.4% | 39.5% | 42.7% |
| 淨現金(現金 − 有息負債) | −7.8B | −8.0B | −8.0B | −7.6B | −6.4B | −5.5B | −5.7B | −5.8B | −5.3B | −5.7B | −5.2B | −4.0B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 718M+20% | – | – | – | 596M | – | – | 665M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 50.1M | – | – | – | 709M | – | – | 0 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 2.4B
| Financial Royalty Assets | 2.3B | 95.1% | +5.2% |
|---|---|---|---|
| Royalty Income Other | 117M | 4.9% | +2.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.4B | +5.1% | 771M | 32.4% | 1.78 | – |
| FY2024 | 2.3B | -3.9% | 859M | 37.9% | 1.91 | – |
| FY2023 | 2.4B | +5.2% | 1.1B | 48.2% | 2.53 | – |
| FY2022 | 2.2B | -2.3% | 42.8M | 1.9% | 0.10 | – |
| FY2021 | 2.3B | +7.9% | 620M | 27.1% | 1.49 | – |
| FY2020 | 2.1B | +17.0% | 975M | 45.9% | 1.32 | – |
| FY2019 | 1.8B | +1.1% | 2.3B | 129.4% | – | – |
| FY2018 | 1.8B | – | 1.4B | 76.8% | – | – |